Related Experiment Video

Updated: Aug 16, 2026

Disrupting Reconsolidation of Fear Memory in Humans by a Noradrenergic β-Blocker
08:32

Disrupting Reconsolidation of Fear Memory in Humans by a Noradrenergic β-Blocker

Published on: December 18, 2014

Sodium Valproate versus Propranolol in paediatric migraine prophylaxis

M R Ashrafi1, R Shabanian, G R Zamani

  • 1Department of Pediatric Neurology, Tehran University of Medical Sciences, Children's Medical Center, 62 Gharib Street, 14194 Tehran, Iran.

European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society
|August 27, 2005
PubMed

Insights

Sodium Valproate and Propranolol are effective for pediatric migraine prophylaxis. Both medications significantly reduced headache frequency, severity, and duration in children, with no significant difference between them.

Area of Science:

  • Neurology
  • Pediatrics
  • Clinical Pharmacology

Background:

  • Pediatric migraine is a common neurological disorder impacting children's quality of life.
  • Effective prophylactic treatments are crucial for managing frequent migraine attacks in pediatric populations.

Purpose of the Study:

  • To compare the efficacy of Sodium Valproate versus Propranolol for pediatric migraine prophylaxis.
  • To evaluate the impact of these treatments on headache frequency, severity, and duration.

Main Methods:

  • A randomized clinical trial involving 120 pediatric patients (3-15 years) with common migraine.
  • Patients were randomized into two groups: Sodium Valproate (Group A) and Propranolol (Group B).
  • The study included baseline, titration, and fixed-dose treatment periods.

Main Results:

  • Both Sodium Valproate and Propranolol demonstrated significant efficacy in migraine prophylaxis.
  • 72% of patients on Sodium Valproate and 69% on Propranolol achieved >50% reduction in monthly headache frequency.
  • Both drugs significantly reduced headache severity and duration, with no statistically significant difference between the groups (p < 0.05).

Conclusions:

  • Sodium Valproate and Propranolol are equally effective in the prophylaxis of common migraine in children.
  • Both medications represent viable therapeutic options for reducing the burden of pediatric migraine.

Related Concept Videos

Adrenergic Antagonists: Pharmacological Actions of &#946;-Receptor Blockers01:27

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in bronchial smooth...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Drug Delivery: Enteral Route01:18

Drug Delivery: Enteral Route

The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
Drugs in...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...